CHLAMYDIA AND GONOCOCCAL INFECTION--IMMUNOBIOLOGY OF FEMALE REPRODUCTIVE TRACT

衣原体和淋球菌感染--女性生殖道的免疫生物学

基本信息

  • 批准号:
    6220943
  • 负责人:
  • 金额:
    $ 15.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1991
  • 资助国家:
    美国
  • 起止时间:
    1991-07-01 至 2003-09-14
  • 项目状态:
    已结题

项目摘要

Growing evidence suggests that the immune system plays an important role in mediating resistance and susceptibility to gonococcal and chlamydial infection and disease. However, inherent flaws in most case- control studies of immune response to these agents limit the ability to understand the direction of causality. Additionally, much of the interaction between chlamydia and gonorrhea and their obligate human hosts occurs at the genital tract mucosa, yet mucosal immune responses to these organisms have been incompletely studied. Lastly, most researchers focus on the effects of immune defenses to the organism, neglecting the effects that the organisms might have on immune responses to other agents. Thus, the twin goals of the proposed research are to prospectively characterize the mucosal and systemic immune responses that mediate protection against or enhancement of susceptibility to gonococcal and chlamydial infection and disease; and to examine the mechanisms by which gonococcal and chlamydial infections alter mucosal immune responses to each other and to HIV. We hypothesize that the balance between antigen specific type I (interferon gamma) and type 2 (JL-4 and IL-10) immune responses determine resistance versus susceptibility to chlamydial and gonococcal infection and disease, and modify susceptibility to infection with other sexually transmitted agents. Two cohorts of commercial sex workers in Nairobi, Kenya will be followed for acquisition of gonococcal and chlamydial infections, and the occurrence of histologically confirmed PID. The relationship of incident and PID will be correlated with baseline measurements of antigen specific immune responses. The relationship of mucosal immune responses evoked by gonococcal and chlamydial infection on susceptibility to infection and disease due to other pathogens will be evaluated by characterizing the cytokine and humoral responses within the lower genital tract including the endometrium among individuals currently infected and 4 to 6 weeks post treatment. These studies will elucidate the specific immune responses that characterize resistance to gonococcal and chlamydial infection, and which correlate with the development of chlamydial and gonococcal PID.
越来越多的证据表明,免疫系统在介导对淋球菌和衣原体感染和疾病的抵抗力和易感性方面起着重要作用。 然而,在大多数病例对照研究中,对这些药物的免疫反应的固有缺陷限制了理解因果关系方向的能力。此外,衣原体和淋病与其专性人类宿主之间的相互作用大多发生在生殖道粘膜,但对这些生物体的粘膜免疫反应尚未完全研究。最后,大多数研究人员关注免疫防御对生物体的影响,忽略了生物体对其他因子的免疫反应可能产生的影响。因此,拟议的研究的双重目标是前瞻性地表征粘膜和全身免疫反应,介导保护或增强对淋球菌和衣原体感染和疾病的易感性;并检查淋球菌和衣原体感染改变粘膜免疫反应的机制。我们假设抗原特异性I型(干扰素γ)和2型(JL-4和IL-10)免疫应答之间的平衡决定了对衣原体和淋球菌感染和疾病的抵抗与易感性,并改变了对其他性传播媒介感染的易感性。 将对肯尼亚内罗毕的两个商业性工作者队列进行淋球菌和衣原体感染的随访,以及组织学证实的PID的发生情况。事件和PID的关系将与抗原特异性免疫应答的基线测量相关。将通过表征当前感染和治疗后4 - 6周个体的下生殖道(包括子宫内膜)内的细胞因子和体液应答,评价淋球菌和衣原体感染诱发的粘膜免疫应答与其他病原体引起的感染和疾病易感性的关系。 这些研究将阐明对淋球菌和衣原体感染具有抵抗力的特异性免疫反应,以及与衣原体和淋球菌PID发展相关的免疫反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT C BRUNHAM其他文献

ROBERT C BRUNHAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT C BRUNHAM', 18)}}的其他基金

CHLAMYDIA AND GONOCOCCAL INFECTION--IMMUNOBIOLOGY OF FEMALE REPRODUCTIVE TRACT
衣原体和淋球菌感染--女性生殖道的免疫生物学
  • 批准号:
    6356483
  • 财政年份:
    2000
  • 资助金额:
    $ 15.29万
  • 项目类别:
CHLAMYDIA AND GONOCOCCAL INFECTION--IMMUNOBIOLOGY OF FEMALE REPRODUCTIVE TRACT
衣原体和淋球菌感染--女性生殖道的免疫生物学
  • 批准号:
    6299636
  • 财政年份:
    2000
  • 资助金额:
    $ 15.29万
  • 项目类别:
HLA ANTIGEN AND ANTIBODY RESPONSE TO C TRACHOMATIS--RISK FOR C SALPINGITIS
HLA 抗原和抗体对沙眼衣原体的反应——衣原体输卵管炎的风险
  • 批准号:
    6099675
  • 财政年份:
    1998
  • 资助金额:
    $ 15.29万
  • 项目类别:
HLA ANTIGEN AND ANTIBODY RESPONSE TO C TRACHOMATIS--RISK FOR C SALPINGITIS
HLA 抗原和抗体对沙眼衣原体的反应——衣原体输卵管炎的风险
  • 批准号:
    6235147
  • 财政年份:
    1997
  • 资助金额:
    $ 15.29万
  • 项目类别:
CELLULAR IMMUNITY AND PATHOGENESIS OF CHLAMYDIA TRACHOMATIS--PID
沙眼衣原体的细胞免疫与发病机制
  • 批准号:
    5205452
  • 财政年份:
  • 资助金额:
    $ 15.29万
  • 项目类别:
HLA ANTIGEN AND ANTIBODY RESPONSE TO C TRACHOMATIS--RISK FOR C SALPINGITIS
HLA 抗原和抗体对沙眼衣原体的反应——衣原体输卵管炎的风险
  • 批准号:
    5205617
  • 财政年份:
  • 资助金额:
    $ 15.29万
  • 项目类别:

相似海外基金

Investigating whether chlamydia trachomatis can increase the infectivity of HPV during genital tract infections
研究沙眼衣原体是否可以增加生殖道感染期间 HPV 的传染性
  • 批准号:
    10648156
  • 财政年份:
    2023
  • 资助金额:
    $ 15.29万
  • 项目类别:
Development of a multivalent rVSV vaccine against different Chlamydia trachomatis urogenital infections
针对不同沙眼衣原体泌尿生殖道感染的多价 rVSV 疫苗的开发
  • 批准号:
    488750
  • 财政年份:
    2023
  • 资助金额:
    $ 15.29万
  • 项目类别:
    Operating Grants
Identifying Chlamydia trachomatis factors that mediate PD-L1 upregulation
鉴定介导 PD-L1 上调的沙眼衣原体因子
  • 批准号:
    10724569
  • 财政年份:
    2023
  • 资助金额:
    $ 15.29万
  • 项目类别:
The influence of rectal Chlamydia trachomatis infections on immunity and incident urogenital infections in women without an indication forrectal screening
直肠沙眼衣原体感染对无直肠筛查指征的女性免疫和泌尿生殖感染事件的影响
  • 批准号:
    10703789
  • 财政年份:
    2023
  • 资助金额:
    $ 15.29万
  • 项目类别:
The role of Chlamydia trachomatis specific HLA-E restricted CD8 T cell responses in clearance of infection
沙眼衣原体特异性 HLA-E 限制性 CD8 T 细胞反应在感染清除中的作用
  • 批准号:
    10646837
  • 财政年份:
    2023
  • 资助金额:
    $ 15.29万
  • 项目类别:
Understanding how motors drive the pathogenesis in host cells infected with Chlamydia trachomatis.
了解马达如何驱动感染沙眼衣原体的宿主细胞的发病机制。
  • 批准号:
    491115
  • 财政年份:
    2023
  • 资助金额:
    $ 15.29万
  • 项目类别:
    Fellowship Programs
CRISPR interference of essential stage-specific gene function in Chlamydia trachomatis
CRISPR 干扰沙眼衣原体必需阶段特异性基因功能
  • 批准号:
    10644789
  • 财政年份:
    2023
  • 资助金额:
    $ 15.29万
  • 项目类别:
Cervicovaginal microbiome, mucosal immunity, and pathogen factors that contribute to spontaneous clearance of Chlamydia trachomatis
宫颈阴道微生物群、粘膜免疫和有助于沙眼衣原体自发清除的病原体因素
  • 批准号:
    10463072
  • 财政年份:
    2022
  • 资助金额:
    $ 15.29万
  • 项目类别:
iSampleSmart!, an innovative, App-facilitated self-sampling screen and treat strategy for common bacterial STIs (Chlamydia trachomatis and Neisseria gonorrhoeae) for Canadian key populations
iSampleSmart!,一种创新的、应用程序辅助的自我采样筛查和治疗策略,适用于加拿大重点人群的常见细菌性传播感染(沙眼衣原体和淋病奈瑟菌)
  • 批准号:
    472740
  • 财政年份:
    2022
  • 资助金额:
    $ 15.29万
  • 项目类别:
    Operating Grants
Dissecting the role of the Inclusion membrane protein IncE, a master multi-tasking scaffolding protein, in the pathogenesis of Chlamydia trachomatis infections
剖析包涵膜蛋白 IncE(一种主要的多任务支架蛋白)在沙眼衣原体感染发病机制中的作用
  • 批准号:
    10453533
  • 财政年份:
    2022
  • 资助金额:
    $ 15.29万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了